JP2019508486A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508486A5
JP2019508486A5 JP2018557200A JP2018557200A JP2019508486A5 JP 2019508486 A5 JP2019508486 A5 JP 2019508486A5 JP 2018557200 A JP2018557200 A JP 2018557200A JP 2018557200 A JP2018557200 A JP 2018557200A JP 2019508486 A5 JP2019508486 A5 JP 2019508486A5
Authority
JP
Japan
Prior art keywords
composition
disease
agent according
individual
inflammatory bowel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508486A (ja
JP6935632B2 (ja
Filing date
Publication date
Priority claimed from FR1650567A external-priority patent/FR3046934B1/fr
Application filed filed Critical
Publication of JP2019508486A publication Critical patent/JP2019508486A/ja
Publication of JP2019508486A5 publication Critical patent/JP2019508486A5/ja
Application granted granted Critical
Publication of JP6935632B2 publication Critical patent/JP6935632B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557200A 2016-01-25 2017-01-23 胃腸炎の処置及び予防のためのフィーカリバクテリウム・プラウスニッツィcncm i−4573株 Active JP6935632B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1650567 2016-01-25
FR1650567A FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
PCT/EP2017/051306 WO2017129515A1 (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm 1-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Publications (3)

Publication Number Publication Date
JP2019508486A JP2019508486A (ja) 2019-03-28
JP2019508486A5 true JP2019508486A5 (https=) 2020-02-13
JP6935632B2 JP6935632B2 (ja) 2021-09-15

Family

ID=55862967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018557200A Active JP6935632B2 (ja) 2016-01-25 2017-01-23 胃腸炎の処置及び予防のためのフィーカリバクテリウム・プラウスニッツィcncm i−4573株

Country Status (17)

Country Link
US (1) US10918678B2 (https=)
EP (1) EP3407902B1 (https=)
JP (1) JP6935632B2 (https=)
CN (1) CN109310714A (https=)
AU (1) AU2017211244B2 (https=)
CA (1) CA3012214C (https=)
ES (1) ES2820338T3 (https=)
FR (1) FR3046934B1 (https=)
HU (1) HUE050810T2 (https=)
IL (1) IL260752B (https=)
LT (1) LT3407902T (https=)
NZ (1) NZ744528A (https=)
PL (1) PL3407902T3 (https=)
PT (1) PT3407902T (https=)
SG (1) SG11201806361PA (https=)
WO (1) WO2017129515A1 (https=)
ZA (1) ZA201805302B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010412B2 (en) * 2011-07-27 2018-07-03 Edwards Lifesciences Corporation Conical crimper
MY201921A (en) * 2017-06-16 2024-03-23 Biofermin Pharmaceutical Co Ltd Agent for preventing or treating fat-associated diseases and/or inflammation
FR3084255B1 (fr) * 2018-07-26 2020-07-03 Institut National De La Recherche Agronomique (Inra) Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu
FR3099053B1 (fr) * 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale
EP3838276A1 (en) * 2019-12-17 2021-06-23 Exeliom Biosciences Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
KR102169795B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도
US20240277785A1 (en) * 2020-07-13 2024-08-22 Ajou University Industry-Academic Cooperation Foundation Composition for preventing or treating inflammatory bowel disease
KR20220021878A (ko) * 2020-08-14 2022-02-22 주식회사 고바이오랩 피칼리박테리움 프라우스니치이 균주 및 그 용도
KR102700146B1 (ko) * 2020-09-28 2024-08-28 씨제이바이오사이언스 주식회사 미생물을 포함하는 염증성 질환 진단 또는 치료용 조성물
CN112402459B (zh) * 2020-10-27 2023-01-31 江南大学 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用
KR102245415B1 (ko) * 2020-12-14 2021-04-29 주식회사 엔테로바이옴 피칼리박테리움 프로스니치 균주 배양 배지 조성물
EP4166150A1 (en) 2021-10-15 2023-04-19 Exeliom Biosciences Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer
EP4209582A4 (en) * 2021-11-18 2023-11-01 Enterobiome Inc. COMPOSITION OF CULTURE MEDIA FOR FAECALIBACTERIUM PRAUSNITZII
EP4309663A1 (en) * 2022-07-19 2024-01-24 Enbiosis Biotechnology Limited Microorganisms synthesizing anti-inflammatory molecules
EP4389134A1 (en) * 2022-12-20 2024-06-26 Exeliom Biosciences Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection
CN118845848B (zh) * 2024-07-01 2025-10-17 温州大学 普氏粪杆菌dsm 17677在制备防治猪流行性腹泻病毒感染产品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105228635A (zh) * 2013-03-05 2016-01-06 格罗宁根大学 Faecalibacterium prausnitzii HTF-F(DSM 26943)在抑制炎症中的应用
LT3218524T (lt) 2014-11-13 2020-07-10 Institut national de recherche pour l`agriculture, l`alimentation et l`environnement Faecalibacterium prausnitzii kamienai, skirti virškinimo trakto skausmo gydymui ir prevencijai

Similar Documents

Publication Publication Date Title
JP2019508486A5 (https=)
JP6444358B2 (ja) ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法
De Vries et al. Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract
KR101840239B1 (ko) 장 염증의 치료에 사용하기 위한 프로바이오틱 조성물
Elshaghabee et al. Mitigation of antibiotic resistance using probiotics, prebiotics and synbiotics. A review
JP5889191B2 (ja) コレステロール低下剤としてのラクトバチルス・プランタルム菌株
Saulnier et al. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods
EP3341001B1 (en) Composition and method for treatment and prophylaxis of intestinal infection and inflammation
US20200121740A1 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
RU2011139211A (ru) Бактериальные штаммы, обладающие высокой противовоспалительной активностью
Furtado et al. Bacteriocinogenic Lactococcus lactis subsp: lactis DF04Mi isolated from goat milk: Evaluation of the probiotic potential
Elshaghabee et al. Dietary management by probiotics, prebiotics and synbiotics for the prevention of antimicrobial resistance
JP6723980B2 (ja) 大腸炎抑制剤
Onyenweaku et al. Research article health benefits of probiotics
JP2015533484A5 (https=)
Giacchi et al. Multistrain probiotics: the present forward the future
JP2017109973A (ja) 機能性胃腸症改善剤
JP2015151385A (ja) 経口感染症の予防治療剤、及び該予防治療剤を含有する医薬品、機能性食品または飲食品添加物
JP5172104B2 (ja) ハンセン病発症予防作用のある菌体含有組成物
Combrinck et al. Probiotics and Prebiotics
Wang Comparison of Microbial Quality of Commercial Probiotic Dietary Supplements
Combrinck et al. Prebiotics, probiotics and synbiotics: An update
Combrinck et al. Probiotics and prebiotics
Engevik et al. Biochemical features of
HRP20201561T1 (hr) Uporaba mikrobnih zajednica za zdravlje ljudi i životinja